ClinicalThought Commentary


Program Content


  • Optimizing Therapy for GN HAP and VAP
    Expert Answers to FAQs: Improving Time to Early Effective Therapy for Resistant Gram-Negative HAP/VAP
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 31, 2023


cover img faculity

Kayla R. Stover Hielscher, PharmD, BCIDP, BCPS, FCCP, FIDSA

Professor of Pharmacy Practice
Program Director, PGY2 Infectious Diseases Residency
University of Mississippi Medical Center
Jackson, Mississippi

cover img faculity

Trevor Van Schooneveld, MD, FSHEA, FACP

Professor, Division of Infectious Diseases
Program Director, Infectious Diseases Fellowship
Medical Director, Antimicrobial Stewardship Program
University of Nebraska Medical Center
Omaha, Nebraska 

Provided by

ProCE Banner
ProCE Banner


Supported by an educational grant from Merck Sharp & Dohme LLC.

Merck Sharp & Dohme, LLC


Society of Infectious Diseases Pharmacists (SIDP)

ProCE Banner